Gu J, Kawai H, Wiederschain D, Yuan Z M
Department of Cancer Cell Biology, Harvard School of Public Health, Boston, Massachusetts 02115, USA.
Cancer Res. 2001 Feb 15;61(4):1741-6.
The majority of p53 mutations are located in the DNA-binding domain of the protein. However, recently a family suffering from Li-Fraumeni syndrome (LFS) has been discovered, some of whom harbor a p53 mutation in exon 4, outside of the core domain. How this mutation affects p53 function and subsequently leads to malignant transformation is not yet clear. Interestingly, the p53 mutation found in this LFS family is localized to the p53 region that we have recently identified as necessary for Mdm2-mediated p53 degradation. We therefore endeavored to study further the LFS-associated p53 mutation at the molecular level by creating an equivalent lesion in a p53 expression construct and functionally characterizing it. Here we demonstrate that a mutation in this region is associated not only with resistance of the mutant p53 to Mdm2-mediated degradation, but also with an impaired response of mutant protein to DNA damage. In addition, the p53(LFS) mutant was found to be defective in its transactivation function, which correlated with its inability to suppress cell growth and to induce apoptosis. The molecular basis for p53(LFS) functional impairment appears to be its predominantly cytoplasmic localization caused by faulty nuclear import mechanism, which, at least in part, resulted from the mutant's decreased affinity to importin.
大多数p53突变位于该蛋白的DNA结合结构域。然而,最近发现了一个患有李-弗劳梅尼综合征(LFS)的家族,其中一些人在核心结构域之外的第4外显子中存在p53突变。这种突变如何影响p53功能并随后导致恶性转化尚不清楚。有趣的是,在这个LFS家族中发现的p53突变定位于我们最近确定的Mdm2介导的p53降解所必需的p53区域。因此,我们试图通过在p53表达构建体中产生等效损伤并对其进行功能表征,在分子水平上进一步研究与LFS相关的p53突变。在这里,我们证明该区域的突变不仅与突变型p53对Mdm2介导的降解的抗性有关,而且与突变蛋白对DNA损伤的反应受损有关。此外,发现p53(LFS)突变体的反式激活功能存在缺陷,这与其无法抑制细胞生长和诱导凋亡相关。p53(LFS)功能受损的分子基础似乎是其错误的核输入机制导致的主要定位于细胞质,这至少部分是由于突变体对输入蛋白的亲和力降低所致。